Reports for RANBAXY PHARMACEUTICALS CANADA INC.
Company Name
RANBAXY PHARMACEUTICALS CANADA INC.
Totals |
||
Shortage reports |
60 |
|
| Actual shortage: | 0 (0%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 0 (0%) | |
| Resolved: | 60 (100%) | |
Discontinuation Reports |
28 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 28 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
39 (44%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RAN-GABAPENTIN | 400MG | CAPSULE | Resolved | 2017-03-13 | 2019-02-04 | 1549 |
| RAN-METFORMIN | 500MG | TABLET | Resolved | 2019-06-24 | 2019-08-19 | 87385 |
| RAN-METFORMIN | 500MG | TABLET | Resolved | 2019-11-08 | 2019-11-26 | 98306 |
| RAN-METFORMIN | 850MG | TABLET | Resolved | 2019-11-01 | 2019-11-26 | 97781 |
| RAN-MONTELUKAST | 4MG | TABLET (CHEWABLE) | Resolved | 2017-05-24 | 2019-02-01 | 11167 |
| RAN-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Resolved | 2017-05-24 | 2019-02-01 | 11133 |
| RAN-NABILONE | 0.25MG | CAPSULE | Resolved | 2017-06-08 | 2019-02-01 | 12334 |
| RAN-NABILONE | 0.5MG | CAPSULE | Resolved | 2017-06-08 | 2019-02-01 | 12342 |
| RAN-NABILONE | 1MG | CAPSULE | Resolved | 2017-06-08 | 2019-02-01 | 12331 |
| RAN-OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-11-22 | 2018-08-21 | 30228 |
| RAN-OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-05-31 | 2019-09-09 | 85347 |
| RAN-OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-10-27 | 2019-02-04 | 27316 |
| RAN-OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-01-20 | 2020-02-02 | 103678 |
| RAN-OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-01-16 | 2019-02-01 | 36060 |
| RAN-OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-02-02 | 2020-03-07 | 105127 |
| RAN-OLANZAPINE ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-01-16 | 2019-02-01 | 36063 |
| RAN-OLANZAPINE ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-05-31 | 2019-08-19 | 85342 |
| RAN-RANITIDINE | 150MG | TABLET | Resolved | 2017-06-08 | 2018-08-23 | 12300 |
| RAN-RANITIDINE | 150MG | TABLET | Resolved | 2019-06-07 | 2020-08-28 | 85902 |
| RAN-RANITIDINE | 150MG | TABLET | Resolved | 2019-06-24 | 2020-08-28 | 87388 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RAN-NABILONE | 1MG | CAPSULE | Discontinued | 2018-05-31 | 2018-06-01 | 50986 |
| RAN-NABILONE | 0.25MG | CAPSULE | Discontinued | 2018-05-31 | 2018-06-01 | 50989 |
| RAN-NABILONE | 0.5MG | CAPSULE | Discontinued | 2018-05-31 | 2018-06-01 | 50992 |
| RAN-OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-08-09 | 2019-08-10 | 91278 |
| RAN-OLANZAPINE ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-08-09 | 2019-08-10 | 91281 |
| RAN-OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-02-02 | 2020-02-02 | 105096 |
| RAN-OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-03-07 | 2020-03-07 | 108130 |
| RAN-OMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Discontinued | 2017-07-21 | 2017-07-21 | 16588 |